Correction to: IL‑15 superagonist N‑803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor‑derived NK cells

Cancer Immunol Immunother. 2021 Nov;70(11):3367. doi: 10.1007/s00262-021-03049-5.

J M R Van der Meer¹, R J A Maas^#¹, K Guldevall^#², K Klarenaar¹, P K J D De Jonge¹, J S Hoogstad-van Evert^{1

3}, A B van der Waart¹, J Cany¹, J T Safrit⁴, J H Lee⁵, E Wagena⁶, P Friedl^{6

7

8}, B Önfelt², L F Massuger³, N P M Schaap⁹, J H Jansen¹, W Hobo¹, H Dolstra¹⁰

¹ Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 8, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
² Department of Applied Physics, Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
³ Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, the Netherlands.
⁴ NantKwest, Culver City, CA, USA.
⁵ ImmunityBio, Culver City, CA, USA.
⁶ Department of Cell Biology, Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
⁷ David H. Koch Center for Applied Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁸ Cancer Genomics Center, Utrecht, The Netherlands.
⁹ Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
¹⁰ Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Geert Grooteplein Zuid 8, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. harry.dolstra@radboudumc.nl.

^# Contributed equally.

No abstract available

Publication types